Deparment of Psychiatry, Igdır State Hospital, Igdır, Turkey.
Department of Psychiatry, Yıldırım Beyazıt University Faculty of Medicine, Ankara Ataturk Training and Research Hospital, Ankara, Turkey.
Gen Hosp Psychiatry. 2014 Mar-Apr;36(2):208-13. doi: 10.1016/j.genhosppsych.2013.11.006. Epub 2013 Nov 27.
Treatment noncompliance is one of the most frequent causes of relapse and recurrence in patients with bipolar I disorder. Treatment compliance among patients with bipolar disorder is affected by individual patients' features, the disease itself, doctor-patient relationships and patients' socio-economic and cultural characteristics. This study aimed to determine the factors affecting treatment compliance during the treatment of bipolar disorder and contribute to current clinical strategies.
Data were collected from 78 volunteers with bipolar I disorder in remission; all volunteers were being treated solely with mood stabilisers. Sociodemographic and clinical data were gathered through a semi-structured interview designed by researchers. The Hamilton Depression Rating Scale and the Young Mania Rating Scale were both administered to assess remission of bipolar I disorder, and a self-report scale, the Medication Adherence Rating Scale, was administered to assess medication adherence.
Treatment compliant patients reported that they had received adequate social support and had been sufficiently informed by their physicians about the illness and treatment. Treatment compliant individuals with higher rates of hospitalisations and the results indicate that the number of depressive episodes adversely affects treatment compliance. There was not a statistically significant difference in treatment compliance based on duration of illness, euthymia, time, total number of episodes, age of onset, predominant polarity, drug doses, number of daily medications, frequency of daily medications, or type of mood stabiliser used.
These results indicate that there are differences between compliant and non-compliant bipolar I disorder patients in terms of adequate social support, information provided by the physician about the illness and treatment, number of depressive episodes and number of hospitalisations.
治疗不依从是双相 I 型障碍患者复发和复发的最常见原因之一。双相障碍患者的治疗依从性受个体患者特征、疾病本身、医患关系以及患者的社会经济和文化特征的影响。本研究旨在确定影响双相障碍治疗期间治疗依从性的因素,并为当前的临床策略做出贡献。
从 78 名缓解期双相 I 型障碍的志愿者中收集数据;所有志愿者均仅使用情绪稳定剂治疗。通过研究人员设计的半结构式访谈收集社会人口统计学和临床数据。使用汉密尔顿抑郁评定量表和 Young 躁狂评定量表评估双相 I 型障碍的缓解情况,使用自我报告量表 Medication Adherence Rating Scale 评估药物依从性。
治疗依从的患者报告说他们得到了足够的社会支持,并从医生那里获得了关于疾病和治疗的充分信息。治疗依从性较高的住院患者比例较高,结果表明抑郁发作次数会对治疗依从性产生不利影响。基于疾病持续时间、病情稳定、时间、总发作次数、发病年龄、主要极性、药物剂量、每日用药次数、每日用药频率或使用的情绪稳定剂类型,治疗依从性没有统计学差异。
这些结果表明,在充分的社会支持、医生提供的关于疾病和治疗的信息、抑郁发作次数和住院次数方面,依从性和不依从性双相 I 型障碍患者之间存在差异。